Rohit Saxena, Vinay Gupta, Rebika Dhiman, Elizabeth Joseph, Sumita Agarkar, R Neena, Damaris Magdalene, Jitendra Jethani, Sandra C Ganesh, Minal Patil, Pooja Gogri, Shailesh Gadaginamath, Pradhnya Sen, Jaspreet Sukhija, Deepak Mishra, Jyoti H Matalia, Anupam Sahu, Smita Kapoor, Shruti Nishanth, Shweta Chaurasia, Neelam Pawar, Nilutparna Deori, Viswanathan Sivaraman, Anamika Bordoloi, Shailja Tibrewal, Davinder Singh, Priyanka Prasad, Swati Phuljhele, Namrata Sharma
OBJECTIVE: The objective of this study was to assess the efficacy of low-dose atropine 0.01% in controlling myopia progression among Indian children over a 2-year period. METHODS: This retrospective study, conducted across 20 centres in India, monitored the progression of myopia over 2 years after initiating treatment with 0.01% atropine eye drops. This included children between 6 and 14 years with baseline myopia ranging from -0.5 D to -6 D, astigmatism≤-1...
January 30, 2024: British Journal of Ophthalmology